Abnormal Proliferation
Induced Pluripotent Stem Cells
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Kim Harnisch1,2, Beata Bode3, Obinna Chijioke4
1Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare cancer. This study identifies novel gene fusions, YAP1::MAML2 and TRIM24::BRAF, expanding the understanding of MIFS genetic diversity and potential therapeutic targets.
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: